[Project on disease-related proteomics and a proteome factory for drug innovation].
The proteome is expected to be thoroughly researched in Post Genome Projects following the completion of the Human Genome Sequencing Project. Many research projects to investigate disease-related proteins are being undertaken worldwide. Analysis of the proteome, which has an intimate involvement in biogenics, should provide a breakthrough in vital activity and provide substantial clues for new treatments, diagnoses and new target of drugs. In the 2003 fiscal year, The Ministry of Health, Labour and Welfare (MHLW) started the Health, Labour and Welfare Scientific Research Founding Program "Disease Related Proteomics". At the time, the Japan Health Sciences Foundation was delegated the project from MHLW, along with the Japan Pharmaceutical Manufactures Association, and established a consortium with 22 pharmaceutical companies for this project, collaborating with the National Institute of Health Science to start the Project on Disease Related Proteomics and a Proteome Factory for Drug Innovation. In this report, the project overview and its facilities will be introduced.